000 | 01846 a2200505 4500 | ||
---|---|---|---|
005 | 20250514042743.0 | ||
264 | 0 | _c20030213 | |
008 | 200302s 0 0 eng d | ||
022 | _a0223-5234 | ||
024 | 7 |
_a10.1016/s0223-5234(02)01357-0 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSantana, Lourdes | |
245 | 0 | 0 |
_aSynthesis and structure-activity relationships of new arylpiperazines: para substitution with electron-withdrawing groups decrease binding to 5-HT(1A) and D(2A) receptors. _h[electronic resource] |
260 |
_bEuropean journal of medicinal chemistry _cJun 2002 |
||
300 |
_a503-10 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_a8-Hydroxy-2-(di-n-propylamino)tetralin _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCoumarins _xchemical synthesis |
650 | 0 | 4 | _aDrug Design |
650 | 0 | 4 | _aElectrons |
650 | 0 | 4 | _aFibroblasts |
650 | 0 | 4 |
_aHippocampus _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 | _aIndicators and Reagents |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aPiperazines _xchemical synthesis |
650 | 0 | 4 |
_aRaclopride _xpharmacology |
650 | 0 | 4 | _aRadioligand Assay |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReceptors, Dopamine D2 _xdrug effects |
650 | 0 | 4 |
_aReceptors, Serotonin _xdrug effects |
650 | 0 | 4 | _aReceptors, Serotonin, 5-HT1 |
650 | 0 | 4 | _aStructure-Activity Relationship |
700 | 1 | _aUriarte, Eugenio | |
700 | 1 | _aFall, Yagamare | |
700 | 1 | _aTeijeira, Marta | |
700 | 1 | _aTerán, Carmen | |
700 | 1 | _aGarcía-Martínez, Emilia | |
700 | 1 | _aTolf, Bo-Ragnar | |
773 | 0 |
_tEuropean journal of medicinal chemistry _gvol. 37 _gno. 6 _gp. 503-10 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0223-5234(02)01357-0 _zAvailable from publisher's website |
999 |
_c12085664 _d12085664 |